Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 9;23(6):2956.
doi: 10.3390/ijms23062956.

Endocrine Disruptors and Endometrial Cancer: Molecular Mechanisms of Action and Clinical Implications, a Systematic Review

Affiliations

Endocrine Disruptors and Endometrial Cancer: Molecular Mechanisms of Action and Clinical Implications, a Systematic Review

Donatella Caserta et al. Int J Mol Sci. .

Abstract

It has been widely demonstrated that endocrine disruptors play a central role in various physiopathological processes of human health. In the literature, various carcinogenic processes have been associated with endocrine disruptors. A review of the molecular mechanisms underlying the interaction between endocrine disruptors and the endometrial cancer has been poorly developed. A systematic review was performed using PubMed®/MEDLINE. A total of 25 in vivo and in vitro works were selected. Numerous endocrine disruptors were analyzed. The most relevant results showed how Bisphenol A (BPA) interacts with the carcinogenesis process on several levels. It has been demonstrated how BPA can interact with hormonal receptors and with different transcription proliferative and antiproliferative factors. Furthermore, the effect of Polycyclic aromatic hydrocarbons on Aryl hydrocarbon receptors was investigated, and the role of flame retardants in promoting proliferation and metastasis was confirmed. The results obtained demonstrate how the mechanisms of action of endocrine disruptors are manifold in the pathophysiology of endometrial cancer, acting on different levels of the cancerogenesis process.

Keywords: Alkylphenol Ethoxylates; Flame Retards; Organoclorurate; Polycyclic aromatic; bisphenol A; cadmium; endocrine disruptors; endometrial cancer; mycotoxins.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
EDCs and EC. Bisphenol A:BPA; E: Estrogen; P:progesteron; fibroblast growth factor receptor: FGFr; Extracellular signal-regulated protein kinases 1 and 2: ERK1/2; Heart- and neural crest derivatives-expressed protein 2:HAND2; epithelial-mesenchymal transition: EMT; cyclooxygenase-2:COX-2; MicroRNAs:miRNAs; increased nuclear translocation of estrogen-related receptor γ (ERRγ); Polycyclic aromatic hydrocarbons: PAHs; aryl hydrocarbon receptor:AhR; poly-glutamine polymorphism: AR-Q; benzo(a)pyrene: BaP; Halogenated flame retardants:HFRs; Ethoxylated alkylene: APEOS; zearalenone:ZEN; Polychlorinated Biphenyls: PCB; p,p’-dichlorodiphenyldichloroethylene: p,p’V-DDE: superoxide dismutase 1:SOD1; red cross: iterferes.

Similar articles

Cited by

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Rodriguez A.C., Blanchard Z., Maurer K.A., Gertz J. Estrogen Signaling in Endometrial Cancer: A Key Oncogenic Pathway with Several Open Questions. Horm. Cancer. 2019;10:51–63. doi: 10.1007/s12672-019-0358-9. - DOI - PMC - PubMed
    1. Morice P., Leary A., Creutzberg C., Abu-Rustum N., Darai E. Endometrial cancer. Lancet. 2016;12:1094–1108. doi: 10.1016/S0140-6736(15)00130-0. - DOI - PubMed
    1. Garikapati K.K., Ammu V.R.K., Krishnamurthy P.T., Chintamaneni P.V., Pindiprolu S.K.S.S. Type-II endometrial cancer: Role of adipokines. Arch. Gynecol. Obstet. 2019;300:239–249. doi: 10.1007/s00404-019-05181-1. - DOI - PubMed
    1. Boussios S., Attygalle A., Hazell S., Moschetta M., McLachlan J., Okines A., Banerjee S. Malignant Ovarian Germ Cell Tumors in Postmenopausal Patients: The Royal Marsden Experience and Literature Review. Anticancer Res. 2015;35:6713–6722. - PubMed

Publication types

Substances

LinkOut - more resources